CN112401227A - 一种湿法工艺复合蛋白型全营养粉及制备方法 - Google Patents
一种湿法工艺复合蛋白型全营养粉及制备方法 Download PDFInfo
- Publication number
- CN112401227A CN112401227A CN202011014597.7A CN202011014597A CN112401227A CN 112401227 A CN112401227 A CN 112401227A CN 202011014597 A CN202011014597 A CN 202011014597A CN 112401227 A CN112401227 A CN 112401227A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- shearing
- mixed material
- oil
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000843 powder Substances 0.000 title claims abstract description 35
- 102000004169 proteins and genes Human genes 0.000 title claims abstract description 23
- 108090000623 proteins and genes Proteins 0.000 title claims abstract description 23
- 235000015097 nutrients Nutrition 0.000 title claims abstract description 21
- 239000002131 composite material Substances 0.000 title claims abstract description 19
- 238000000034 method Methods 0.000 title claims abstract description 19
- 238000002360 preparation method Methods 0.000 title claims abstract description 17
- 230000008569 process Effects 0.000 title claims abstract description 16
- 229940088594 vitamin Drugs 0.000 claims abstract description 42
- 229930003231 vitamin Natural products 0.000 claims abstract description 42
- 235000013343 vitamin Nutrition 0.000 claims abstract description 42
- 239000011782 vitamin Substances 0.000 claims abstract description 42
- 239000000679 carrageenan Substances 0.000 claims abstract description 28
- 229940113118 carrageenan Drugs 0.000 claims abstract description 28
- 235000010418 carrageenan Nutrition 0.000 claims abstract description 28
- 229920001525 carrageenan Polymers 0.000 claims abstract description 28
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims abstract description 28
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 claims abstract description 28
- 108010038807 Oligopeptides Proteins 0.000 claims abstract description 26
- 102000015636 Oligopeptides Human genes 0.000 claims abstract description 26
- 108010076119 Caseins Proteins 0.000 claims abstract description 25
- 102000011632 Caseins Human genes 0.000 claims abstract description 25
- 150000001875 compounds Chemical class 0.000 claims abstract description 25
- 229940080237 sodium caseinate Drugs 0.000 claims abstract description 24
- 235000018102 proteins Nutrition 0.000 claims abstract description 22
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 21
- 235000010755 mineral Nutrition 0.000 claims abstract description 21
- 239000011707 mineral Substances 0.000 claims abstract description 21
- 108010033929 calcium caseinate Proteins 0.000 claims abstract description 19
- 239000005913 Maltodextrin Substances 0.000 claims abstract description 16
- 229920002774 Maltodextrin Polymers 0.000 claims abstract description 16
- 229940035034 maltodextrin Drugs 0.000 claims abstract description 16
- 239000003921 oil Substances 0.000 claims abstract description 16
- 235000019198 oils Nutrition 0.000 claims abstract description 16
- 229960003080 taurine Drugs 0.000 claims abstract description 14
- 241000251468 Actinopterygii Species 0.000 claims abstract description 13
- 235000010469 Glycine max Nutrition 0.000 claims abstract description 13
- 244000068988 Glycine max Species 0.000 claims abstract description 13
- 108010046377 Whey Proteins Proteins 0.000 claims abstract description 13
- 102000007544 Whey Proteins Human genes 0.000 claims abstract description 13
- 239000002773 nucleotide Substances 0.000 claims abstract description 13
- 125000003729 nucleotide group Chemical group 0.000 claims abstract description 13
- 235000021119 whey protein Nutrition 0.000 claims abstract description 13
- PHIQHXFUZVPYII-ZCFIWIBFSA-N (R)-carnitine Chemical compound C[N+](C)(C)C[C@H](O)CC([O-])=O PHIQHXFUZVPYII-ZCFIWIBFSA-N 0.000 claims abstract description 12
- 108010011485 Aspartame Proteins 0.000 claims abstract description 12
- 241000283690 Bos taurus Species 0.000 claims abstract description 12
- 235000018290 Musa x paradisiaca Nutrition 0.000 claims abstract description 12
- 235000004347 Perilla Nutrition 0.000 claims abstract description 12
- 239000000605 aspartame Substances 0.000 claims abstract description 12
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 claims abstract description 12
- 229960003438 aspartame Drugs 0.000 claims abstract description 12
- 235000010357 aspartame Nutrition 0.000 claims abstract description 12
- 239000003240 coconut oil Substances 0.000 claims abstract description 12
- 235000019864 coconut oil Nutrition 0.000 claims abstract description 12
- 210000003022 colostrum Anatomy 0.000 claims abstract description 12
- 235000021277 colostrum Nutrition 0.000 claims abstract description 12
- 235000008390 olive oil Nutrition 0.000 claims abstract description 12
- 239000004006 olive oil Substances 0.000 claims abstract description 12
- 239000003549 soybean oil Substances 0.000 claims abstract description 12
- 235000012424 soybean oil Nutrition 0.000 claims abstract description 12
- UFTFJSFQGQCHQW-UHFFFAOYSA-N triformin Chemical compound O=COCC(OC=O)COC=O UFTFJSFQGQCHQW-UHFFFAOYSA-N 0.000 claims abstract description 12
- 229920001202 Inulin Polymers 0.000 claims abstract description 10
- 229940029339 inulin Drugs 0.000 claims abstract description 10
- JYJIGFIDKWBXDU-MNNPPOADSA-N inulin Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)OC[C@]1(OC[C@]2(OC[C@]3(OC[C@]4(OC[C@]5(OC[C@]6(OC[C@]7(OC[C@]8(OC[C@]9(OC[C@]%10(OC[C@]%11(OC[C@]%12(OC[C@]%13(OC[C@]%14(OC[C@]%15(OC[C@]%16(OC[C@]%17(OC[C@]%18(OC[C@]%19(OC[C@]%20(OC[C@]%21(OC[C@]%22(OC[C@]%23(OC[C@]%24(OC[C@]%25(OC[C@]%26(OC[C@]%27(OC[C@]%28(OC[C@]%29(OC[C@]%30(OC[C@]%31(OC[C@]%32(OC[C@]%33(OC[C@]%34(OC[C@]%35(OC[C@]%36(O[C@@H]%37[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O%37)O)[C@H]([C@H](O)[C@@H](CO)O%36)O)[C@H]([C@H](O)[C@@H](CO)O%35)O)[C@H]([C@H](O)[C@@H](CO)O%34)O)[C@H]([C@H](O)[C@@H](CO)O%33)O)[C@H]([C@H](O)[C@@H](CO)O%32)O)[C@H]([C@H](O)[C@@H](CO)O%31)O)[C@H]([C@H](O)[C@@H](CO)O%30)O)[C@H]([C@H](O)[C@@H](CO)O%29)O)[C@H]([C@H](O)[C@@H](CO)O%28)O)[C@H]([C@H](O)[C@@H](CO)O%27)O)[C@H]([C@H](O)[C@@H](CO)O%26)O)[C@H]([C@H](O)[C@@H](CO)O%25)O)[C@H]([C@H](O)[C@@H](CO)O%24)O)[C@H]([C@H](O)[C@@H](CO)O%23)O)[C@H]([C@H](O)[C@@H](CO)O%22)O)[C@H]([C@H](O)[C@@H](CO)O%21)O)[C@H]([C@H](O)[C@@H](CO)O%20)O)[C@H]([C@H](O)[C@@H](CO)O%19)O)[C@H]([C@H](O)[C@@H](CO)O%18)O)[C@H]([C@H](O)[C@@H](CO)O%17)O)[C@H]([C@H](O)[C@@H](CO)O%16)O)[C@H]([C@H](O)[C@@H](CO)O%15)O)[C@H]([C@H](O)[C@@H](CO)O%14)O)[C@H]([C@H](O)[C@@H](CO)O%13)O)[C@H]([C@H](O)[C@@H](CO)O%12)O)[C@H]([C@H](O)[C@@H](CO)O%11)O)[C@H]([C@H](O)[C@@H](CO)O%10)O)[C@H]([C@H](O)[C@@H](CO)O9)O)[C@H]([C@H](O)[C@@H](CO)O8)O)[C@H]([C@H](O)[C@@H](CO)O7)O)[C@H]([C@H](O)[C@@H](CO)O6)O)[C@H]([C@H](O)[C@@H](CO)O5)O)[C@H]([C@H](O)[C@@H](CO)O4)O)[C@H]([C@H](O)[C@@H](CO)O3)O)[C@H]([C@H](O)[C@@H](CO)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 JYJIGFIDKWBXDU-MNNPPOADSA-N 0.000 claims abstract description 10
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims abstract description 9
- 150000003271 galactooligosaccharides Chemical class 0.000 claims abstract description 9
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 8
- 239000000126 substance Substances 0.000 claims abstract description 8
- 240000008790 Musa x paradisiaca Species 0.000 claims abstract 3
- 244000124853 Perilla frutescens Species 0.000 claims abstract 3
- 238000010008 shearing Methods 0.000 claims description 67
- 239000000463 material Substances 0.000 claims description 60
- 230000001804 emulsifying effect Effects 0.000 claims description 39
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 claims description 20
- 238000002156 mixing Methods 0.000 claims description 20
- 238000003756 stirring Methods 0.000 claims description 20
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims description 18
- 239000000203 mixture Substances 0.000 claims description 16
- -1 compound vitamin Chemical class 0.000 claims description 15
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 claims description 12
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 claims description 12
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 claims description 12
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 11
- 235000016709 nutrition Nutrition 0.000 claims description 11
- 239000011772 phylloquinone Substances 0.000 claims description 11
- 239000011691 vitamin B1 Substances 0.000 claims description 11
- 239000011709 vitamin E Substances 0.000 claims description 11
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 10
- 239000001763 2-hydroxyethyl(trimethyl)azanium Substances 0.000 claims description 10
- 235000019743 Choline chloride Nutrition 0.000 claims description 10
- 239000011665 D-biotin Substances 0.000 claims description 10
- 235000000638 D-biotin Nutrition 0.000 claims description 10
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 claims description 10
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 10
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 10
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 10
- SGMZJAMFUVOLNK-UHFFFAOYSA-M choline chloride Chemical compound [Cl-].C[N+](C)(C)CCO SGMZJAMFUVOLNK-UHFFFAOYSA-M 0.000 claims description 10
- 229960003178 choline chloride Drugs 0.000 claims description 10
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 claims description 10
- 229960000367 inositol Drugs 0.000 claims description 10
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 claims description 10
- PPASLZSBLFJQEF-RKJRWTFHSA-M sodium ascorbate Substances [Na+].OC[C@@H](O)[C@H]1OC(=O)C(O)=C1[O-] PPASLZSBLFJQEF-RKJRWTFHSA-M 0.000 claims description 10
- 229960005055 sodium ascorbate Drugs 0.000 claims description 10
- 235000019155 vitamin A Nutrition 0.000 claims description 10
- 239000011719 vitamin A Substances 0.000 claims description 10
- 239000011715 vitamin B12 Substances 0.000 claims description 10
- 239000011716 vitamin B2 Substances 0.000 claims description 10
- 239000011726 vitamin B6 Substances 0.000 claims description 10
- 239000011647 vitamin D3 Substances 0.000 claims description 10
- 229940045997 vitamin a Drugs 0.000 claims description 10
- 150000003722 vitamin derivatives Chemical class 0.000 claims description 10
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 9
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 claims description 9
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims description 9
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 claims description 9
- 229960000304 folic acid Drugs 0.000 claims description 9
- 235000019152 folic acid Nutrition 0.000 claims description 9
- 239000011724 folic acid Substances 0.000 claims description 9
- 239000011777 magnesium Substances 0.000 claims description 9
- 229910052749 magnesium Inorganic materials 0.000 claims description 9
- 239000000395 magnesium oxide Substances 0.000 claims description 9
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 claims description 9
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 claims description 9
- 239000011734 sodium Substances 0.000 claims description 9
- 229910052708 sodium Inorganic materials 0.000 claims description 9
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims description 8
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims description 8
- 239000011575 calcium Substances 0.000 claims description 8
- 229910052791 calcium Inorganic materials 0.000 claims description 8
- 239000007788 liquid Substances 0.000 claims description 8
- 239000011574 phosphorus Substances 0.000 claims description 8
- 229910052698 phosphorus Inorganic materials 0.000 claims description 8
- 238000001694 spray drying Methods 0.000 claims description 8
- 230000001954 sterilising effect Effects 0.000 claims description 8
- 238000004659 sterilization and disinfection Methods 0.000 claims description 8
- 239000011701 zinc Substances 0.000 claims description 8
- 229910052725 zinc Inorganic materials 0.000 claims description 8
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 7
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 7
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 claims description 7
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 7
- 229910052802 copper Inorganic materials 0.000 claims description 7
- 239000010949 copper Substances 0.000 claims description 7
- 238000004945 emulsification Methods 0.000 claims description 7
- 238000000265 homogenisation Methods 0.000 claims description 7
- 239000011572 manganese Substances 0.000 claims description 7
- 229910052748 manganese Inorganic materials 0.000 claims description 7
- 239000011591 potassium Substances 0.000 claims description 7
- 229910052700 potassium Inorganic materials 0.000 claims description 7
- 229910052711 selenium Inorganic materials 0.000 claims description 7
- 239000011669 selenium Substances 0.000 claims description 7
- PNDPGZBMCMUPRI-UHFFFAOYSA-N iodine Chemical compound II PNDPGZBMCMUPRI-UHFFFAOYSA-N 0.000 claims description 6
- 230000035764 nutrition Effects 0.000 claims description 5
- 239000008346 aqueous phase Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- MBWXNTAXLNYFJB-LKUDQCMESA-N phylloquinone Chemical compound C1=CC=C2C(=O)C(C/C=C(C)/CCCC(C)CCCC(C)CCCC(C)C)=C(C)C(=O)C2=C1 MBWXNTAXLNYFJB-LKUDQCMESA-N 0.000 claims description 4
- 239000007787 solid Substances 0.000 claims description 4
- 239000008347 soybean phospholipid Substances 0.000 claims description 4
- 238000005303 weighing Methods 0.000 claims description 4
- 229910052742 iron Inorganic materials 0.000 claims description 3
- 235000013305 food Nutrition 0.000 abstract description 17
- 230000000295 complement effect Effects 0.000 abstract description 2
- 238000013329 compounding Methods 0.000 abstract description 2
- 241000234295 Musa Species 0.000 description 9
- 241000229722 Perilla <angiosperm> Species 0.000 description 9
- 229940091250 magnesium supplement Drugs 0.000 description 8
- 208000002720 Malnutrition Diseases 0.000 description 7
- 229960005069 calcium Drugs 0.000 description 7
- 235000000824 malnutrition Nutrition 0.000 description 7
- 230000001071 malnutrition Effects 0.000 description 7
- 208000015380 nutritional deficiency disease Diseases 0.000 description 7
- 229960003975 potassium Drugs 0.000 description 6
- 229940091258 selenium supplement Drugs 0.000 description 6
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000008280 blood Substances 0.000 description 4
- 210000004369 blood Anatomy 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 229960000869 magnesium oxide Drugs 0.000 description 3
- NLKNQRATVPKPDG-UHFFFAOYSA-M potassium iodide Chemical compound [K+].[I-] NLKNQRATVPKPDG-UHFFFAOYSA-M 0.000 description 3
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 2
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 206010025476 Malabsorption Diseases 0.000 description 2
- 208000004155 Malabsorption Syndromes Diseases 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 150000001413 amino acids Chemical class 0.000 description 2
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 2
- 239000001506 calcium phosphate Substances 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 229940108928 copper Drugs 0.000 description 2
- 235000019700 dicalcium phosphate Nutrition 0.000 description 2
- FWBOFUGDKHMVPI-UHFFFAOYSA-K dicopper;2-oxidopropane-1,2,3-tricarboxylate Chemical compound [Cu+2].[Cu+2].[O-]C(=O)CC([O-])(C([O-])=O)CC([O-])=O FWBOFUGDKHMVPI-UHFFFAOYSA-K 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 230000001079 digestive effect Effects 0.000 description 2
- 201000010099 disease Diseases 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 208000030159 metabolic disease Diseases 0.000 description 2
- 235000019796 monopotassium phosphate Nutrition 0.000 description 2
- 229910000402 monopotassium phosphate Inorganic materials 0.000 description 2
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 2
- 235000019799 monosodium phosphate Nutrition 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- PJNZPQUBCPKICU-UHFFFAOYSA-N phosphoric acid;potassium Chemical compound [K].OP(O)(O)=O PJNZPQUBCPKICU-UHFFFAOYSA-N 0.000 description 2
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 2
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 2
- 235000019731 tricalcium phosphate Nutrition 0.000 description 2
- 229940078499 tricalcium phosphate Drugs 0.000 description 2
- 229910000391 tricalcium phosphate Inorganic materials 0.000 description 2
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 2
- PMYDPQQPEAYXKD-UHFFFAOYSA-N 3-hydroxy-n-naphthalen-2-ylnaphthalene-2-carboxamide Chemical compound C1=CC=CC2=CC(NC(=O)C3=CC4=CC=CC=C4C=C3O)=CC=C21 PMYDPQQPEAYXKD-UHFFFAOYSA-N 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- 239000004475 Arginine Substances 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186000 Bifidobacterium Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- PMVSDNDAUGGCCE-TYYBGVCCSA-L Ferrous fumarate Chemical compound [Fe+2].[O-]C(=O)\C=C\C([O-])=O PMVSDNDAUGGCCE-TYYBGVCCSA-L 0.000 description 1
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 description 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 description 1
- 240000001046 Lactobacillus acidophilus Species 0.000 description 1
- 235000013956 Lactobacillus acidophilus Nutrition 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- HLCFGWHYROZGBI-JJKGCWMISA-M Potassium gluconate Chemical compound [K+].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O HLCFGWHYROZGBI-JJKGCWMISA-M 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 description 1
- ZOIORXHNWRGPMV-UHFFFAOYSA-N acetic acid;zinc Chemical compound [Zn].CC(O)=O.CC(O)=O ZOIORXHNWRGPMV-UHFFFAOYSA-N 0.000 description 1
- FRHBOQMZUOWXQL-UHFFFAOYSA-L ammonium ferric citrate Chemical compound [NH4+].[Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FRHBOQMZUOWXQL-UHFFFAOYSA-L 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 1
- 230000037208 balanced nutrition Effects 0.000 description 1
- 235000019046 balanced nutrition Nutrition 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229910000019 calcium carbonate Inorganic materials 0.000 description 1
- 229960003563 calcium carbonate Drugs 0.000 description 1
- 235000010216 calcium carbonate Nutrition 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 235000011148 calcium chloride Nutrition 0.000 description 1
- FNAQSUUGMSOBHW-UHFFFAOYSA-H calcium citrate Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O FNAQSUUGMSOBHW-UHFFFAOYSA-H 0.000 description 1
- 239000001354 calcium citrate Substances 0.000 description 1
- 229960004256 calcium citrate Drugs 0.000 description 1
- 235000013927 calcium gluconate Nutrition 0.000 description 1
- 239000004227 calcium gluconate Substances 0.000 description 1
- 229960004494 calcium gluconate Drugs 0.000 description 1
- BRPQOXSCLDDYGP-UHFFFAOYSA-N calcium oxide Chemical compound [O-2].[Ca+2] BRPQOXSCLDDYGP-UHFFFAOYSA-N 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 235000012255 calcium oxide Nutrition 0.000 description 1
- 235000011132 calcium sulphate Nutrition 0.000 description 1
- MKJXYGKVIBWPFZ-CEOVSRFSSA-L calcium;(2s)-2-hydroxypropanoate Chemical compound [Ca+2].C[C@H](O)C([O-])=O.C[C@H](O)C([O-])=O MKJXYGKVIBWPFZ-CEOVSRFSSA-L 0.000 description 1
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 229940116318 copper carbonate Drugs 0.000 description 1
- 229910000365 copper sulfate Inorganic materials 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- GEZOTWYUIKXWOA-UHFFFAOYSA-L copper;carbonate Chemical compound [Cu+2].[O-]C([O-])=O GEZOTWYUIKXWOA-UHFFFAOYSA-L 0.000 description 1
- 208000002925 dental caries Diseases 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- MHJAJDCZWVHCPF-UHFFFAOYSA-L dimagnesium phosphate Chemical compound [Mg+2].OP([O-])([O-])=O MHJAJDCZWVHCPF-UHFFFAOYSA-L 0.000 description 1
- 229910000395 dimagnesium phosphate Inorganic materials 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- BVTBRVFYZUCAKH-UHFFFAOYSA-L disodium selenite Chemical compound [Na+].[Na+].[O-][Se]([O-])=O BVTBRVFYZUCAKH-UHFFFAOYSA-L 0.000 description 1
- 208000035475 disorder Diseases 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 201000006549 dyspepsia Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 229960004642 ferric ammonium citrate Drugs 0.000 description 1
- 229960002413 ferric citrate Drugs 0.000 description 1
- 235000007144 ferric diphosphate Nutrition 0.000 description 1
- 239000011706 ferric diphosphate Substances 0.000 description 1
- CADNYOZXMIKYPR-UHFFFAOYSA-B ferric pyrophosphate Chemical compound [Fe+3].[Fe+3].[Fe+3].[Fe+3].[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O.[O-]P([O-])(=O)OP([O-])([O-])=O CADNYOZXMIKYPR-UHFFFAOYSA-B 0.000 description 1
- 229940036404 ferric pyrophosphate Drugs 0.000 description 1
- 235000002332 ferrous fumarate Nutrition 0.000 description 1
- 239000011773 ferrous fumarate Substances 0.000 description 1
- 229960000225 ferrous fumarate Drugs 0.000 description 1
- 235000013924 ferrous gluconate Nutrition 0.000 description 1
- 239000004222 ferrous gluconate Substances 0.000 description 1
- 229960001645 ferrous gluconate Drugs 0.000 description 1
- 229960001781 ferrous sulfate Drugs 0.000 description 1
- 235000003891 ferrous sulphate Nutrition 0.000 description 1
- 239000011790 ferrous sulphate Substances 0.000 description 1
- 239000011737 fluorine Substances 0.000 description 1
- 229910052731 fluorine Inorganic materials 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000012631 food intake Nutrition 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 229930195712 glutamate Natural products 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000003871 intestinal function Effects 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 235000000011 iron ammonium citrate Nutrition 0.000 description 1
- 239000004313 iron ammonium citrate Substances 0.000 description 1
- BAUYGSIQEAFULO-UHFFFAOYSA-L iron(2+) sulfate (anhydrous) Chemical compound [Fe+2].[O-]S([O-])(=O)=O BAUYGSIQEAFULO-UHFFFAOYSA-L 0.000 description 1
- 229910000359 iron(II) sulfate Inorganic materials 0.000 description 1
- NPFOYSMITVOQOS-UHFFFAOYSA-K iron(III) citrate Chemical compound [Fe+3].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NPFOYSMITVOQOS-UHFFFAOYSA-K 0.000 description 1
- VRIVJOXICYMTAG-IYEMJOQQSA-L iron(ii) gluconate Chemical compound [Fe+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O VRIVJOXICYMTAG-IYEMJOQQSA-L 0.000 description 1
- 229940039695 lactobacillus acidophilus Drugs 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- 229910001629 magnesium chloride Inorganic materials 0.000 description 1
- 235000015778 magnesium gluconate Nutrition 0.000 description 1
- 239000001755 magnesium gluconate Substances 0.000 description 1
- 229960003035 magnesium gluconate Drugs 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- IAKLPCRFBAZVRW-XRDLMGPZSA-L magnesium;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate;hydrate Chemical compound O.[Mg+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O IAKLPCRFBAZVRW-XRDLMGPZSA-L 0.000 description 1
- 235000014012 manganese gluconate Nutrition 0.000 description 1
- 239000011683 manganese gluconate Substances 0.000 description 1
- 229940072543 manganese gluconate Drugs 0.000 description 1
- 229940099596 manganese sulfate Drugs 0.000 description 1
- 235000007079 manganese sulphate Nutrition 0.000 description 1
- 239000011702 manganese sulphate Substances 0.000 description 1
- OXHQNTSSPHKCPB-IYEMJOQQSA-L manganese(2+);(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Mn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O OXHQNTSSPHKCPB-IYEMJOQQSA-L 0.000 description 1
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 1
- SQQMAOCOWKFBNP-UHFFFAOYSA-L manganese(II) sulfate Chemical compound [Mn+2].[O-]S([O-])(=O)=O SQQMAOCOWKFBNP-UHFFFAOYSA-L 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 229910052757 nitrogen Inorganic materials 0.000 description 1
- 235000003715 nutritional status Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020777 polyunsaturated fatty acids Nutrition 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 239000001508 potassium citrate Substances 0.000 description 1
- 229960002635 potassium citrate Drugs 0.000 description 1
- QEEAPRPFLLJWCF-UHFFFAOYSA-K potassium citrate (anhydrous) Chemical compound [K+].[K+].[K+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O QEEAPRPFLLJWCF-UHFFFAOYSA-K 0.000 description 1
- 235000011082 potassium citrates Nutrition 0.000 description 1
- 235000013926 potassium gluconate Nutrition 0.000 description 1
- 239000004224 potassium gluconate Substances 0.000 description 1
- 229960003189 potassium gluconate Drugs 0.000 description 1
- JLKDVMWYMMLWTI-UHFFFAOYSA-M potassium iodate Chemical compound [K+].[O-]I(=O)=O JLKDVMWYMMLWTI-UHFFFAOYSA-M 0.000 description 1
- 235000006666 potassium iodate Nutrition 0.000 description 1
- 239000001230 potassium iodate Substances 0.000 description 1
- 229940093930 potassium iodate Drugs 0.000 description 1
- 235000007715 potassium iodide Nutrition 0.000 description 1
- 235000013406 prebiotics Nutrition 0.000 description 1
- 102000004196 processed proteins & peptides Human genes 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 150000004671 saturated fatty acids Chemical class 0.000 description 1
- 238000004904 shortening Methods 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- 239000001509 sodium citrate Substances 0.000 description 1
- NLJMYIDDQXHKNR-UHFFFAOYSA-K sodium citrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O NLJMYIDDQXHKNR-UHFFFAOYSA-K 0.000 description 1
- 235000009518 sodium iodide Nutrition 0.000 description 1
- 235000018716 sodium selenate Nutrition 0.000 description 1
- 239000011655 sodium selenate Substances 0.000 description 1
- 229960001881 sodium selenate Drugs 0.000 description 1
- 235000015921 sodium selenite Nutrition 0.000 description 1
- 239000011781 sodium selenite Substances 0.000 description 1
- 229960001471 sodium selenite Drugs 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 239000011573 trace mineral Substances 0.000 description 1
- 235000013619 trace mineral Nutrition 0.000 description 1
- 235000013337 tricalcium citrate Nutrition 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 230000029663 wound healing Effects 0.000 description 1
- 239000004246 zinc acetate Substances 0.000 description 1
- 229960000314 zinc acetate Drugs 0.000 description 1
- 235000013904 zinc acetate Nutrition 0.000 description 1
- 235000005074 zinc chloride Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 229960001939 zinc chloride Drugs 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
- 235000000193 zinc lactate Nutrition 0.000 description 1
- 239000011576 zinc lactate Substances 0.000 description 1
- 229940050168 zinc lactate Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229960001296 zinc oxide Drugs 0.000 description 1
- 235000014692 zinc oxide Nutrition 0.000 description 1
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 1
- 229960001763 zinc sulfate Drugs 0.000 description 1
- 229910000368 zinc sulfate Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/40—Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/13—Nucleic acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/18—Peptides; Protein hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/19—Dairy proteins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Mycology (AREA)
- Nutrition Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Inorganic Chemistry (AREA)
- Biochemistry (AREA)
- Pediatric Medicine (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
Abstract
本发明公开了一种湿法工艺复合蛋白型全营养粉及制备方法，涉及医用食品技术领域，包含如下重量份的组份：乳清蛋白58‑466份、酪蛋白酸钙62‑500份、牛初乳0.56‑4.5份、大豆低聚肽0.56‑4.5份、海洋鱼低聚肽0.56‑4.5份、紫苏油2.5‑20份、椰子油10‑86份、大豆油28‑225份、橄榄油8‑68份、中链甘油三酯29‑233份、麦芽糊精227‑1816份、菊粉3.4‑27份、低聚半乳糖1.7‑13.5份、复合矿物质10‑79份、复合维生素5.6‑45份、牛磺酸0.375‑3份、左旋肉碱0.068‑0.54份、核苷酸0.1‑0.8份、磷脂11.25‑90份、酪蛋白酸钠0.42‑3.33份、卡拉胶0.42‑3.33份、香蕉粉末香精1‑8份、阿斯巴甜0.625‑5份。本发明采用乳清蛋白和酪蛋白酸钙相复合的形式，两种蛋白互相补充，易于消化吸收。
Description
技术领域
本发明涉及医用食品技术领域，具体为一种湿法工艺复合蛋白型全营养粉及制备方法。
背景技术
医用食品，全称特殊医学用途配方食品(foods for special medical purposes，FSMP)，特殊医学用途配方食品是为了满足进食受限、消化吸收障碍、代谢紊乱或特定疾病状态人群对营养素或膳食的特殊需要，专门加工配制而成的配方食品。该类产品必须在医生或临床营养师指导下，单独食用或与其他食品配合食用。特殊医学用途配方食品是食品不是药品，不能对疾病和临床症状进行预防和治疗，但可以作为一种营养补充途径，起到营养“治疗”的作用，并改善病人消化道结构、促进伤口愈合、提高病人生存率、缩短住院时间。
病人生病住院期间因忌口、进食受限、消化吸收障碍导致营养不良，仅靠日常膳食无法满足其营养需求，研究表明营养不良病人的住院时间显著长于无营养不良病人。据报道，我国有1.4亿住院患者，有1.1亿住院患者存有营养不良或营养风险，有4-5千万住院患者存在严重营养不良和营养风险。其中癌症病人营养不良发生率约为40％-80％，糖尿病病人营养不良发生率高达50％以上。改善病人的营养状况，对预防感染，减少并发症，缩短住院期，提高病人生存质量和延长生存时间有重要意义。而目前，针对病人的营养全面、价格优惠的全营养配方食品比较少。因此，开发一种复合蛋白型全营养配方食品，具有重大的经济效益和社会意义。
发明内容
本发明的目的在于提供一种湿法工艺复合蛋白型全营养粉及制备方法。
为实现上述目的，本发明提供如下技术方案：
一种湿法工艺复合蛋白型全营养粉，包含如下重量份的组份：乳清蛋白58-466份、酪蛋白酸钙62-500份、牛初乳0.56-4.5份、大豆低聚肽0.56-4.5份、海洋鱼低聚肽0.56-4.5份、紫苏油2.5-20份、椰子油10-86份、大豆油28-225份、橄榄油8-68份、中链甘油三酯29-233份、麦芽糊精227-1816份、菊粉3.4-27份、低聚半乳糖1.7-13.5份、复合矿物质10-79份、复合维生素5.6-45份、牛磺酸0.375-3份、左旋肉碱0.068-0.54份、核苷酸0.1-0.8份、磷脂11.25-90份、酪蛋白酸钠0.42-3.33份、卡拉胶0.42-3.33份、香蕉粉末香精1-8份、阿斯巴甜0.625-5份。
进一步地，所述的复合维生素为维生素A、维生素D3、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇中的一种、几种或全部混合。
进一步地，所述的复合维生素为水溶性维生素和脂溶性维生素，其中水溶性维生素包含维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇，脂溶性维生素包含维生素A、维生素D3、维生素E、维生素K1。
进一步地，所述的复合矿物质为钙、磷、钠、镁、铁、锌、钾、硒、碘、铜、锰中的一种、几种或全部混合。
与现有技术相比，本发明的有益效果是：本产品配方根据GB29922-2016《食品安全国家标准特殊医学用途配方食品通则》的严格要求，采用乳清蛋白和酪蛋白酸钙相复合的形式，两种蛋白互相补充，易于消化吸收。并且本发明富含脂肪酸、益生元、微量元素等，营养全面均衡，能量科学合理，可作为单一营养来源满足进食受限、消化吸收障碍、代谢紊乱状态人群的营养需求。
本发明所述配方食品的蛋白质来源于优质蛋白，乳清蛋白含有人体所需的全部20种氨基酸，赖氨酸和精氨酸含量丰富，且是含硫氨基酸的良好来源，吸收快，利用度高，具有独特的生物活性，并具有抗疲劳、抗氧化、降血脂、降血糖、降血压等功能，是理想的动物蛋白来源。酪蛋白酸钙中的酪蛋白可以提高新陈代谢率，并提供谷氨酸盐，对希望增加体重和防止蛀牙的人都有益处。海洋鱼低聚肽、大豆低聚肽等小分子肽，能为人体提供不同形式的氮源，易于患者消化吸收。
本发明所述配方食品富含必需脂肪酸，饱和脂肪酸、单不饱和脂肪酸、多不饱和脂肪酸合理配比，有助于保持机体免疫力。
本产品中含有菊粉，菊粉具有预防肥胖、调节血糖、降低血脂水平、预防心脑血管疾病、改善肠道功能、抗癌等作用。低聚半乳糖是人体肠道中双歧杆菌、嗜酸乳酸杆菌等有益菌极好的营养源和有效的增殖因子，可以改善患者肠道内的消化吸收功能。
本发明中包含人体不可缺少的牛磺酸，可提高机体的免疫能力，同时含有核苷酸等免疫营养素，并提高机体抗氧化能力、抗辐射能力以及对外界的应激能力。
具体实施方式
下面对本发明实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是本发明一部分实施例，而不是全部的实施例。基于本发明中的实施例，本领域普通技术人员在没有做出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1：
一种湿法工艺复合蛋白型全营养粉，包含如下重量份的组份：乳清蛋白58份、酪蛋白酸钙62份、牛初乳0.56份、大豆低聚肽0.56份、海洋鱼低聚肽0.56份、紫苏油2.5份、椰子油10份、大豆油28份、橄榄油8份、中链甘油三酯29份、麦芽糊精227份、菊粉3.4份、低聚半乳糖1.7份、复合矿物质10份、复合维生素5.6份、牛磺酸0.375份、左旋肉碱0.068份、核苷酸0.1份、磷脂11.25份、酪蛋白酸钠0.42份、卡拉胶0.42份、香蕉粉末香精1份、阿斯巴甜0.625份。所述的复合维生素为维生素A、维生素D3、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇。所述的复合维生素为水溶性维生素和脂溶性维生素，其中水溶性维生素包含维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇，脂溶性维生素包含维生素A、维生素D3、维生素E、维生素K1。所述的复合矿物质为钙、磷、钠、镁、铁、锌、钾、硒、碘、铜、锰。所述复合矿物质中各组分的含量优选如下：钠89mg、钾128mg、铜110μg、镁24mg、铁1.2mg、锌2mg、锰300μg、钙84mg、磷51mg、碘12μg、氟1μg、硒10.8μg；复合矿物质中钠来源于柠檬酸钠、碳酸氢钠、磷酸氢二钠、磷酸二氢钠和氯化钠中的一种或多种；
钾来源于柠檬酸钾、葡萄糖酸钾、磷酸二氢钾、磷酸氢二钾和氯化钾中的一种或多种；铜来源于硫酸铜、柠檬酸铜、碳酸铜和柠檬酸铜中的一种或多种；镁来源于硫酸镁、葡萄糖酸镁、氯化镁、氧化镁、碳酸镁和磷酸氢镁中的一种或多种；铁来源于硫酸亚铁、焦磷酸铁、柠檬酸铁、柠檬酸铁铵、葡萄糖酸亚铁和富马酸亚铁中的一种或多种；锌来源于硫酸锌、葡萄糖酸锌、氧化锌、乙酸锌、乳酸锌、柠檬酸锌和氯化锌中的一种或多种；锰来源于硫酸锰、葡萄糖酸锰中的一种或多种；钙来源于L-乳酸钙、碳酸钙、葡萄糖酸钙、柠檬酸钙、磷酸氢钙、氯化钙、磷酸三钙、氧化钙和硫酸钙中的一种或多种；磷来源于磷酸二氢钾、磷酸三钙、磷酸氢钙和磷酸二氢钠中的一种或多种；碘来源于碘化钾、碘酸钾和碘化钠中的一种或多种；硒来源于亚硒酸钠和硒酸钠中的一种或两种。
实施例2：
一种湿法工艺复合蛋白型全营养粉，包含如下重量份的组份：乳清蛋白466份、酪蛋白酸钙500份、牛初乳4.5份、大豆低聚肽4.5份、海洋鱼低聚肽4.5份、紫苏油20份、椰子油86份、大豆油225份、橄榄油68份、中链甘油三酯233份、麦芽糊精1816份、菊粉27份、低聚半乳糖13.5份、复合矿物质79份、复合维生素45份、牛磺酸3份、左旋肉碱0.54份、核苷酸0.8份、磷脂90份、酪蛋白酸钠3.33份、卡拉胶3.33份、香蕉粉末香精8份、阿斯巴甜5份。所述的复合维生素为维生素A、维生素D3、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12。所述的复合矿物质为钙、磷、钠、镁、铁、锌。
实施例3：
一种湿法工艺复合蛋白型全营养粉，包含如下重量份的组份：乳清蛋白60份、酪蛋白酸钙480份、牛初乳0.6份、大豆低聚肽4.3份、海洋鱼低聚肽0.65份、紫苏油18份、椰子油13份、大豆油213份、橄榄油11份、中链甘油三酯225份、麦芽糊精230份、菊粉25份、低聚半乳糖2.2份、复合矿物质75份、复合维生素5.8份、牛磺酸2.8份、左旋肉碱0.086份、核苷酸1.75份、磷脂11.5份、酪蛋白酸钠3.2份、卡拉胶0.48份、香蕉粉末香精7.3份、阿斯巴甜0.65份。所述的复合维生素为维生素A、维生素D3、维生素E、维生素K1、维生素B1、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇合。所述的复合矿物质为钙、磷、钠、镁、铁、碘、铜、锰。
实施例4：
一种湿法工艺复合蛋白型全营养粉，包含如下重量份的组份：乳清蛋白452份、酪蛋白酸钙65份、牛初乳4.3份、大豆低聚肽0.62份、海洋鱼低聚肽4.4份、紫苏油2.7份、椰子油85份、大豆油29份、橄榄油66份、中链甘油三酯31份、麦芽糊精1746份、菊粉3.6份、低聚半乳糖13份、复合矿物质15份、复合维生素42份、牛磺酸0.39份、左旋肉碱0.5份、核苷酸0.15份、磷脂88份、酪蛋白酸钠0.49份、卡拉胶3份、香蕉粉末香精1.6份、阿斯巴甜4.8份。所述的复合维生素为维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙氯化胆碱、D-生物素、肌醇。所述的复合矿物质为钠、镁、铁、锌、钾、硒、锰。
实施例5：
一种湿法工艺复合蛋白型全营养粉，包含如下重量份的组份：乳清蛋白260份、酪蛋白酸钙260份、牛初乳2.6份、大豆低聚肽3.3份、海洋鱼低聚肽1.5份、紫苏油2.6份、椰子油26份、大豆油126份、橄榄油26份、中链甘油三酯226份、麦芽糊精1600份、菊粉26份、低聚半乳糖2.6份、复合矿物质26份、复合维生素26份、牛磺酸2.6份、左旋肉碱0.26份、核苷酸0.3份、磷脂26份、酪蛋白酸钠2.6份、卡拉胶0.9份、香蕉粉末香精3份、阿斯巴甜2.6份。所述的复合维生素为维生素A、维生素D3、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇。所述的复合维生素为水溶性维生素和脂溶性维生素，其中水溶性维生素包含维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇，脂溶性维生素包含维生素A、维生素D3、维生素E、维生素K1。所述的复合矿物质为钙、磷、钠、镁、铁、锌、钾、硒、碘、铜、锰。
实施例6：
结合实施例1中的一种湿法工艺复合蛋白型全营养粉的制备方法，包括以下步骤：
(1)准确称量原辅料
初混料a：50％的麦芽糊精、复合矿物质；
初混料b：50％的麦芽糊精，水溶性维生素、牛磺酸、左旋肉碱、核苷酸；
初混料c：酪蛋白酸钙、牛初乳、大豆低聚肽、海洋鱼低聚肽、阿斯巴甜、香蕉粉末香精；
初混料d：紫苏油、椰子油、大豆油、橄榄油、中链甘油三酯、脂溶性维生素、大豆磷脂；
初混料e：氧化镁、卡拉胶、酪蛋白酸钙分别单独称量于不同的容器中；
(2)水锅配制
分别使用60℃温水溶解酪蛋白酸钠和卡拉胶，搅拌至基本完全溶解；
在容器中加入60℃温水，并置于60℃热水浴中，将氧化镁溶于温水中，逐渐加入柠檬酸调节溶液至澄清pH3，再逐渐加入氢氧化钾，调节至pH6；
将初混料a加入上述容器中充分搅拌，使用立式剪切乳化机10000r/min剪切至完全溶解；将初混料c加入到上述溶液中充分搅拌，然后使用立式剪切乳化机16000r/min剪切至完全溶解；将初混料b加入到上述溶液中充分搅拌，使用立式剪切乳化机16000r/min剪切至完全溶解；将溶解的卡拉胶和酪蛋白酸钠分别使用立式剪切乳化机10000r/min剪切至完全溶解，然后加入上述溶液，再使用立式剪切乳化机16000r/min剪切1min；
(3)油锅配制
将初混料d置于塑料烧杯中，并在60～65℃恒温水浴锅中搅拌至基本溶解，使用立式剪切乳化机10000r/min剪切至完全溶解；然后转移至上述水相溶液中，使用立式剪切乳化机16000r/min剪切1min，然后静置10min后定容，并剪切1min得到待乳化液；
(4)剪切乳化
使用卧式高速剪切乳化机，采用10000r/min进行剪切乳化15次，待乳化结束后静置10min再进行均质；
(5)高压均质
将剪切乳化的料液使用高压均质机进行进一步分散乳化，采用二次均质，第一次均质压力为200bar，第二次均质压力为400bar；
(6)高温瞬时灭菌
将均质后溶液进行高温瞬时灭菌；
(7)喷雾干燥
将灭菌溶液冷却后进行喷雾干燥得到固体粉末成品。
实施例7：
结合实施例2中的一种湿法工艺复合蛋白型全营养粉的制备方法，包括以下步骤：
(1)准确称量原辅料
初混料a：50％的麦芽糊精、复合矿物质；
初混料b：50％的麦芽糊精，水溶性维生素、牛磺酸、左旋肉碱、核苷酸；
初混料c：酪蛋白酸钙、牛初乳、大豆低聚肽、海洋鱼低聚肽、阿斯巴甜、香蕉粉末香精；
初混料d：紫苏油、椰子油、大豆油、橄榄油、中链甘油三酯、脂溶性维生素、大豆磷脂；
初混料e：氧化镁、卡拉胶、酪蛋白酸钙分别单独称量于不同的容器中；
(2)水锅配制
分别使用65℃温水溶解酪蛋白酸钠和卡拉胶，搅拌至基本完全溶解；
在容器中加入65℃温水，并置于65℃热水浴中，将氧化镁溶于温水中，逐渐加入柠檬酸调节溶液至澄清pH4，再逐渐加入氢氧化钾，调节至pH7；
将初混料a加入上述容器中充分搅拌，使用立式剪切乳化机10000r/min剪切至完全溶解；将初混料c加入到上述溶液中充分搅拌，然后使用立式剪切乳化机16000r/min剪切至完全溶解；将初混料b加入到上述溶液中充分搅拌，使用立式剪切乳化机16000r/min剪切至完全溶解；将溶解的卡拉胶和酪蛋白酸钠分别使用立式剪切乳化机10000r/min剪切至完全溶解，然后加入上述溶液，再使用立式剪切乳化机16000r/min剪切1min；
(3)油锅配制
将初混料d置于塑料烧杯中，并在60～65℃恒温水浴锅中搅拌至基本溶解，使用立式剪切乳化机10000r/min剪切至完全溶解；然后转移至上述水相溶液中，使用立式剪切乳化机16000r/min剪切1min，然后静置10min后定容，并剪切1min得到待乳化液；
(4)剪切乳化
使用卧式高速剪切乳化机，采用16000r/min进行剪切乳化20次，待乳化结束后静置15min再进行均质；
(5)高压均质
将剪切乳化的料液使用高压均质机进行进一步分散乳化，采用二次均质，第一次均质压力为300bar，第二次均质压力为500bar；
(6)高温瞬时灭菌
将均质后溶液进行高温瞬时灭菌；
(7)喷雾干燥
将灭菌溶液冷却后进行喷雾干燥得到固体粉末成品。
实施例8：
结合实施例3-5中任意一个所述的湿法工艺复合蛋白型全营养粉的制备方法，包括以下步骤：
(1)准确称量原辅料
初混料a：50％的麦芽糊精、复合矿物质；
初混料b：50％的麦芽糊精，水溶性维生素、牛磺酸、左旋肉碱、核苷酸；
初混料c：酪蛋白酸钙、牛初乳、大豆低聚肽、海洋鱼低聚肽、阿斯巴甜、香蕉粉末香精；
初混料d：紫苏油、椰子油、大豆油、橄榄油、中链甘油三酯、脂溶性维生素、大豆磷脂；
初混料e：氧化镁、卡拉胶、酪蛋白酸钙分别单独称量于不同的容器中；
(2)水锅配制
分别使用64℃温水溶解酪蛋白酸钠和卡拉胶，搅拌至基本完全溶解；
在容器中加入62℃温水，并置于63℃热水浴中，将氧化镁溶于温水中，逐渐加入柠檬酸调节溶液至澄清pH4，再逐渐加入氢氧化钾，调节至pH6；
将初混料a加入上述容器中充分搅拌，使用立式剪切乳化机10000r/min剪切至完全溶解；将初混料c加入到上述溶液中充分搅拌，然后使用立式剪切乳化机16000r/min剪切至完全溶解；将初混料b加入到上述溶液中充分搅拌，使用立式剪切乳化机16000r/min剪切至完全溶解；将溶解的卡拉胶和酪蛋白酸钠分别使用立式剪切乳化机10000r/min剪切至完全溶解，然后加入上述溶液，再使用立式剪切乳化机16000r/min剪切1min；
(3)油锅配制
将初混料d置于塑料烧杯中，并在60～65℃恒温水浴锅中搅拌至基本溶解，使用立式剪切乳化机10000r/min剪切至完全溶解；然后转移至上述水相溶液中，使用立式剪切乳化机16000r/min剪切1min，然后静置10min后定容，并剪切1min得到待乳化液；
(4)剪切乳化
使用卧式高速剪切乳化机，采用12000r/min进行剪切乳化18次，待乳化结束后静置13min再进行均质；
(5)高压均质
将剪切乳化的料液使用高压均质机进行进一步分散乳化，采用二次均质，第一次均质压力为260bar，第二次均质压力为480bar；
(6)高温瞬时灭菌
将均质后溶液进行高温瞬时灭菌；
(7)喷雾干燥
将灭菌溶液冷却后进行喷雾干燥得到固体粉末成品。
对于本领域技术人员而言，显然本发明不限于上述示范性实施例的细节，而且在不背离本发明的精神或基本特征的情况下，能够以其他的具体形式实现本发明。因此，无论从哪一点来看，均应将实施例看作是示范性的，而且是非限制性的，本发明的范围由所附权利要求而不是上述说明限定，因此旨在将落在权利要求的等同要件的含义和范围内的所有变化囊括在本发明内。
Claims (5)
1.一种湿法工艺复合蛋白型全营养粉，其特征在于：包含如下重量份的组份：乳清蛋白58-466份、酪蛋白酸钙62-500份、牛初乳0.56-4.5份、大豆低聚肽0.56-4.5份、海洋鱼低聚肽0.56-4.5份、紫苏油2.5-20份、椰子油10-86份、大豆油28-225份、橄榄油8-68份、中链甘油三酯29-233份、麦芽糊精227-1816份、菊粉3.4-27份、低聚半乳糖1.7-13.5份、复合矿物质10-79份、复合维生素5.6-45份、牛磺酸0.375-3份、左旋肉碱0.068-0.54份、核苷酸0.1-0.8份、磷脂11.25-90份、酪蛋白酸钠0.42-3.33份、卡拉胶0.42-3.33份、香蕉粉末香精1-8份、阿斯巴甜0.625-5份。
2.根据权利要求1所述一种湿法工艺复合蛋白型全营养粉，其特征在于：所述的复合维生素为维生素A、维生素D3、维生素E、维生素K1、维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇中的一种、几种或全部混合。
3.根据权利要求2所述一种湿法工艺复合蛋白型全营养粉，其特征在于：所述的复合维生素为水溶性维生素和脂溶性维生素，其中水溶性维生素包含维生素B1、维生素B2、维生素B6、维生素B12、L-抗坏血酸钠、D-泛酸钙、叶酸、烟酰胺、氯化胆碱、D-生物素、肌醇，脂溶性维生素包含维生素A、维生素D3、维生素E、维生素K1。
4.根据权利要求1所述一种湿法工艺复合蛋白型全营养粉，其特征在于：所述的复合矿物质为钙、磷、钠、镁、铁、锌、钾、硒、碘、铜、锰中的一种、几种或全部混合。
5.一种如权利要求1-4中任意一条所述湿法工艺复合蛋白型全营养粉的制备方法，其特征在于：包括以下步骤：
(1)准确称量原辅料
初混料a：50％的麦芽糊精、复合矿物质；
初混料b：50％的麦芽糊精，水溶性维生素、牛磺酸、左旋肉碱、核苷酸；
初混料c：酪蛋白酸钙、牛初乳、大豆低聚肽、海洋鱼低聚肽、阿斯巴甜、香蕉粉末香精；
初混料d：紫苏油、椰子油、大豆油、橄榄油、中链甘油三酯、脂溶性维生素、大豆磷脂；
初混料e：氧化镁、卡拉胶、酪蛋白酸钙分别单独称量于不同的容器中；
(2)水锅配制
分别使用60～65℃温水溶解酪蛋白酸钠和卡拉胶，搅拌至基本完全溶解；
在容器中加入60～65℃温水，并置于60～65℃热水浴中，将氧化镁溶于温水中，逐渐加入柠檬酸调节溶液至澄清pH3～4，再逐渐加入氢氧化钾，调节至pH6～7；
将初混料a加入上述容器中充分搅拌，使用立式剪切乳化机10000r/min剪切至完全溶解；将初混料c加入到上述溶液中充分搅拌，然后使用立式剪切乳化机16000r/min剪切至完全溶解；将初混料b加入到上述溶液中充分搅拌，使用立式剪切乳化机16000r/min剪切至完全溶解；将溶解的卡拉胶和酪蛋白酸钠分别使用立式剪切乳化机10000r/min剪切至完全溶解，然后加入上述溶液，再使用立式剪切乳化机16000r/min剪切1min；
(3)油锅配制
将初混料d置于塑料烧杯中，并在60～65℃恒温水浴锅中搅拌至基本溶解，使用立式剪切乳化机10000r/min剪切至完全溶解；然后转移至上述水相溶液中，使用立式剪切乳化机16000r/min剪切1min，然后静置10min后定容，并剪切1min得到待乳化液；
(4)剪切乳化
使用卧式高速剪切乳化机，采用10000-16000r/min进行剪切乳化15-20次，待乳化结束后静置10-15min再进行均质；
(5)高压均质
将剪切乳化的料液使用高压均质机进行进一步分散乳化，采用二次均质，第一次均质压力为200-300bar，第二次均质压力为400-500bar；
(6)高温瞬时灭菌
将均质后溶液进行高温瞬时灭菌；
(7)喷雾干燥
将灭菌溶液冷却后进行喷雾干燥得到固体粉末成品。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011014597.7A CN112401227A (zh) | 2020-09-24 | 2020-09-24 | 一种湿法工艺复合蛋白型全营养粉及制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202011014597.7A CN112401227A (zh) | 2020-09-24 | 2020-09-24 | 一种湿法工艺复合蛋白型全营养粉及制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN112401227A true CN112401227A (zh) | 2021-02-26 |
Family
ID=74854060
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202011014597.7A Withdrawn CN112401227A (zh) | 2020-09-24 | 2020-09-24 | 一种湿法工艺复合蛋白型全营养粉及制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN112401227A (zh) |
-
2020
- 2020-09-24 CN CN202011014597.7A patent/CN112401227A/zh not_active Withdrawn
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN112535283A (zh) | 一种全营养配方粉 | |
| CN113397164A (zh) | 一种提高免疫力的特殊医学用途全营养配方食品及其制备方法 | |
| IE55320B1 (en) | Infant foods | |
| CN111616232A (zh) | 一种促进骨骼生长的儿童奶粉及其制备方法 | |
| CN111602720A (zh) | 一种中老年配方奶粉 | |
| CN107440088A (zh) | 提高手术、放化疗肿瘤患者免疫力的营养物及其制备方法 | |
| CN107048137A (zh) | 一种适用于慢性肾病患者的低磷乳清蛋白粉及其制备方法 | |
| CN110786388A (zh) | 一种促进儿童身高发育的奶粉及其制备方法 | |
| CN111657497A (zh) | 抗食物蛋白过敏的生酮饮食及其制备方法 | |
| CN107751992A (zh) | 用于糖尿病合并肾病患者的肠内营养组合物及其制备方法 | |
| CN108391811A (zh) | 一种肿瘤全营养配方食品及其应用 | |
| CN108157953A (zh) | 一种全营养配方食品及其制备方法 | |
| CN112998080A (zh) | 一种添加蛋黄磷脂、大豆磷脂和乳磷脂的婴幼儿配方奶粉 | |
| CN110881526A (zh) | 一种促进铁吸收的组合物及其应用 | |
| CN105558046A (zh) | 一种用于肝病患者的特殊医学用途配方食品及其制备方法 | |
| CN113841739A (zh) | 一种调理血糖、肠胃、三高人群的奶粉配方及其制备方法 | |
| Pampaloni et al. | Parmigiano Reggiano cheese and bone health | |
| CN105432792A (zh) | 一种学龄前儿童基础营养奶粉、营养粉套装及制备方法 | |
| CN101269210A (zh) | 适用治疗难治性癫痫的生酮混合制剂 | |
| CN112369599A (zh) | 一种酪蛋白型特殊医学用途配方乳剂及其制备方法 | |
| CN108432880A (zh) | 一种适用于备孕期女士的配方奶粉及其制备方法 | |
| CN108741086A (zh) | 一种适于长期健身的运动补剂及其制备方法 | |
| CN112401227A (zh) | 一种湿法工艺复合蛋白型全营养粉及制备方法 | |
| CN110584120A (zh) | 骨健康组合物 | |
| US11077085B2 (en) | Dietary macro/micronutritional supplement for patients undergoing kidney dialysis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| WW01 | Invention patent application withdrawn after publication |
Application publication date: 20210226 |
|
| WW01 | Invention patent application withdrawn after publication |